AMRN Q3 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M-36.7% YoY

Gross Profit

$63M69.9% margin

Operating Income

-$5M-5.7% margin

Net Income

-$5M-5.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-4.8%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$908M

Total Liabilities

$320M

Stockholders' Equity

$588M

Cash & Equivalents

$240M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$142M	-36.7%
Gross Profit	$63M	$112M	-43.8%
Operating Income	-$5M	-$13M	+60.7%
Net Income	-$5M	-$13M	+60.9%

Revenue Segments

Product

$89M99%

Licensing And Royalty

$656,0001%